Potential protease inhibitors based on a functionalized cyclic sulfamide scaffold.

Area of Science:

• Medicinal Chemistry
• Enzyme Inhibition
• Organic Synthesis

Background:

• Proteolytic enzymes play crucial roles in various physiological and pathological processes.
• Developing small molecule inhibitors for proteolytic enzymes is a key area in drug discovery.
• Cyclic sulfamides offer a versatile scaffold for designing enzyme inhibitors.

Purpose of the Study:

• To explore the design and synthesis of functionalized cyclic sulfamides as potential inhibitors of proteolytic enzymes.
• To develop a combinatorial approach for generating diverse libraries of cyclic sulfamides for lead discovery.
• To investigate the inhibitory activity of synthesized compounds against human leukocyte elastase.

Main Methods:

• Design and synthesis of functionalized cyclic sulfamide scaffolds.
• Combinatorial parallel synthesis utilizing three diversity sites on the scaffold.
• Assembly of the scaffold starting from (DL) serine methyl ester.
• Screening of generated compounds against human leukocyte elastase.
• Enzyme kinetic studies to determine inhibition mechanisms.

Main Results:

• A series of functionalized cyclic sulfamides were successfully synthesized.
• The scaffold proved amenable to combinatorial synthesis, generating prospecting libraries.
• Compounds were screened against human leukocyte elastase, identifying active inhibitors.
• Modification of the P(1) recognition element significantly impacted inhibitory activity.
• Inhibition was characterized as apparent hyperbolic partial mixed-type.

Conclusions:

• Functionalized cyclic sulfamides represent a promising scaffold for developing proteolytic enzyme inhibitors.
• The developed synthetic strategy allows for facile library generation for drug discovery.
• The P(1) recognition element is critical for potent inhibition of human leukocyte elastase.
• Cyclic sulfamides demonstrate potential as therapeutic agents targeting specific enzymes.